Advertisement
UK markets close in 2 hours 46 minutes
  • FTSE 100

    7,956.71
    +24.73 (+0.31%)
     
  • FTSE 250

    19,865.89
    +55.23 (+0.28%)
     
  • AIM

    743.21
    +1.10 (+0.15%)
     
  • GBP/EUR

    1.1694
    +0.0025 (+0.22%)
     
  • GBP/USD

    1.2635
    -0.0003 (-0.02%)
     
  • Bitcoin GBP

    56,126.69
    +278.46 (+0.50%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,250.65
    +2.16 (+0.04%)
     
  • DOW

    39,795.59
    +35.51 (+0.09%)
     
  • CRUDE OIL

    82.57
    +1.22 (+1.50%)
     
  • GOLD FUTURES

    2,228.50
    +15.80 (+0.71%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,485.80
    +8.71 (+0.05%)
     
  • CAC 40

    8,220.12
    +15.31 (+0.19%)
     

BRIEF-CSPC Pharmaceutical Announces A Product Licensing Agreement

April 18 (Reuters) - CSPC Pharmaceutical Group Ltd :

* UNIT ENTERED PRODUCT LICENSING AGREEMENT WITH GALAXY BIO, INC. FOR LICENSING & COMMERCIALIZATION OF "PACLITAXEL FOR INJECTION"

* GALAXY BIO TO PAY PRESCRIBED PCT OF NET PROFIT OF PRODUCT IN TERRITORY TO UNIT AS SALES ROYALTY DURING 20 YEAR TERM Source text for Eikon: Further company coverage: